Authors:
Leblond, V
Levy, V
Maloisel, F
Cazin, B
Fermand, JP
Harousseau, JL
Remenieras, L
Porcher, R
Gardembas, M
Marit, G
Deconinck, E
Desablens, B
Guilhot, F
Philippe, G
Stamatoullas, A
Guibon, O
Citation: V. Leblond et al., Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease, BLOOD, 98(9), 2001, pp. 2640-2644
Authors:
Colombat, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Delwail, V
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoullas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Thieblemont, C
Montestruc, F
Mathieu-Boue, A
Benzohra, A
Solal-Celigny, P
Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106
Authors:
Buchonnet, G
Lenain, P
Ruminy, P
Lepretre, S
Stamatoullas, A
Parmentier, F
Jardin, F
Duval, C
Tilly, H
Bastard, C
Citation: G. Buchonnet et al., Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3 ' BCL2 breakpoints and evidence of a new cluster, LEUKEMIA, 14(9), 2000, pp. 1563-1569
Authors:
Thomas, X
Dombret, H
Cordonnier, C
Pigneux, A
Gardin, C
Guerci, A
Vekhoff, A
Sadoun, A
Stamatoullas, A
Fegueux, N
Maloisel, F
Cahn, JY
Reman, O
Gratecos, N
Berthou, C
Huguet, F
Kotoucek, P
Travade, P
Buzyn, A
de Revel, T
Vilque, JP
Naccache, P
Chomienne, C
Degos, L
Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Authors:
Casasnovas, RO
Haioun, C
Dumontet, C
Gabarre, J
Richard, B
Lederlin, P
Caillot, D
Stamatoullas, A
Morel, P
Quesnel, B
Blay, JY
Bouabdallah, K
Gisselbrecht, C
Citation: Ro. Casasnovas et al., Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas, HAEMATOLOG, 85(5), 2000, pp. 502-507
Authors:
de Botton, S
Chevret, S
Sanz, M
Dombret, H
Thomas, X
Guerci, A
Fey, M
Rayon, C
Huguet, F
Sotto, JJ
Gardin, C
Makhoul, PC
Travade, P
Solary, E
Fegueux, N
Bordessoule, D
San Miguel, J
Link, H
Desablens, B
Stamatoullas, A
Deconinck, E
Geiser, K
Hess, U
Maloisel, F
Castaigne, S
Preudhomme, C
Chomienne, C
Degos, L
Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Authors:
Jardin, F
Stamatoullas, A
Fruchart, C
D'Anjou, J
Clement, J
Tilly, H
Citation: F. Jardin et al., Intramedullary spinal cord metastasis and leptomeningeal involvement in Hodgkin's disease: a case report and literature review., REV MED IN, 20(3), 1999, pp. 267-271
Authors:
Fenaux, P
Chastang, C
Chevret, S
Sanz, M
Dombret, H
Archimbaud, E
Fey, M
Rayon, C
Huguet, F
Sotto, JJ
Gardin, C
Makhoul, PC
Travade, P
Solary, E
Fegueux, N
Bordessoule, D
San Miguel, J
Link, H
Desablens, B
Stamatoullas, A
Deconinck, E
Maloisel, F
Castaigne, S
Preudhomme, C
Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200